What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon‐like Peptide‐1 Receptor Agonists (GLP‐1 RAs)? A Scoping Review

What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon‐like Peptide‐1 Receptor Agonists (GLP‐1 RAs)? A Scoping Review

ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are a pharmacological treatment option for both diabetes and weight loss. Qualitative evidence is vital in providing greater understanding of patients, practitioners and carers experience of taking or delivering GLP‐1 RAs. Thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Sam Febrey, Michael Nunns, Jill Buckland, Rebecca Abbott, Alison Bethel, Rebecca Whear, Kate Boddy, G. J. Melendez‐Torres, Jo Thompson Coon, Liz Shaw
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Health Expectations
Subjects:
diabetes
glucagon‐Like peptide 1 receptor agonists (GLP‐1 RAs)
obesity
qualitative
scoping review
weight loss
Online Access:https://doi.org/10.1111/hex.70251
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/hex.70251

Similar Items